Within this screening process, we will ascertain additive or synergistic effects of the antibodies with chemotherapeutic drugs, small molecules that inhibit molecular interactions or enzymatic activity of proteins involved in cell signaling, or inhibitors of protein kinases over-expressed in tumor cells. Here, WEE1 is linked to neoplasm.